You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 55 No. 9, September 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (52)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Aging/ Geriatrics
 •Alzheimer Disease
 •Dementias
 •Alert me on articles by topic

New Neuropathological Criteria for Alzheimer Disease

Arch Neurol. 1998;55:1174-1176.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

ALZHEIMER DESCRIBED neurofibrillary tangles (NFTs) and senile plaques in the brain of a patient with dementia in 1907.1 These 2 neuropathological hallmarks have been the cornerstone of neuropathological diagnosis ever since. However, since a few of these lesions are detected in most individuals older than 65 years by neuropathological examination, it has been controversial which lesions constitute normal aging and which actually portend a clinical dementia. The National Institute on Aging (NIA) has convened several workshops since the early 1980s to create a common definition of the neuropathological diagnosis of Alzheimer disease (AD). This has been an iterative process, and recently new recommendations have been proposed.

In November 1996, a meeting sponsored by the NIA and the Ronald and Nancy Reagan Research Institute of the Alzheimer's Association was convened to discuss updating the neuropathological criteria for AD according to current understanding of the pathophysiological features of the illness. The meeting . . . [Full Text of this Article]


RELATED ARTICLE

Regional Distribution of Neuritic Plaques in the Nondemented Elderly and Subjects With Very Mild Alzheimer Disease
Vahram Haroutunian, Daniel P. Perl, Dushyant P. Purohit, Deborah Marin, Khalid Khan, Melinda Lantz, Kenneth L. Davis, and Richard C. Mohs
Arch Neurol. 1998;55(9):1185-1191.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Dementia at old age: a clinical end-point of atherosclerotic disease
Blauw et al.
Eur Heart J Suppl 2001;3:N16-N19.
ABSTRACT  

Absence of cognitive impairment or decline in preclinical Alzheimer's disease
Goldman et al.
Neurology 2001;56:361-367.
ABSTRACT | FULL TEXT  

Criteria for Diagnosis of Vascular Dementia
Loeb and Meyer
Arch Neurol 2000;57:1382-1383.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.